bxp inc. - BXP
BXP
Close Chg Chg %
79.56 1.21 1.52%
Closed Market
80.77
+1.21 (1.52%)
Volume: 792.41K
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: bxp inc. - BXP
BXP Key Data
| Open $79.72 | Day Range 79.65 - 81.68 |
| 52 Week Range 52.61 - 90.11 | Market Cap $12.58B |
| Shares Outstanding 158.11M | Public Float 157.72M |
| Beta 1.19 | Rev. Per Employee N/A |
| P/E Ratio 34.51 | EPS $2.31 |
| Yield 492.71% | Dividend $0.98 |
| EX-DIVIDEND DATE Sep 30, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.25M |
BXP Performance
| 1 Week | 2.85% | ||
| 1 Month | -7.15% | ||
| 3 Months | 10.46% | ||
| 1 Year | 50.38% | ||
| 5 Years | -41.30% |
BXP Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
22
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 82.278 | |
| Number of Ratings | 22 | Current Quarters Estimate | 0.50 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 2.045 | |
| Last Quarter’s Earnings | 0.53 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.21 | Next Fiscal Year Estimate | 1.963 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 4 | 8 | 8 |
| Mean Estimate | 0.50 | 0.40 | 2.04 | 1.96 |
| High Estimates | 0.57 | 0.45 | 2.20 | 3.20 |
| Low Estimate | 0.39 | 0.34 | 1.84 | 1.37 |
| Coefficient of Variance | 12.29 | 11.90 | 5.54 | 28.37 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 8 | 8 | 7 |
| OVERWEIGHT | 0 | 1 | 1 |
| HOLD | 13 | 13 | 14 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 1 | 1 | 1 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Bxp Inc. - BXP
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Bxp Inc. - BXP
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Oct 2, 2024 | Bruce W. Duncan Director | 9,282 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | Tony West Director | 2,023 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | Joel Irwin Klein Director | 18,658 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | Mary E. Kipp Director | 4,998 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | Carol B. Einiger Director | 30,853 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | William H Walton Director | 6,933 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Oct 2, 2024 | Matthew J. Lustig Director | 16,713 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 11, 2024 | Raymond A. Ritchey Senior EVP | 21,835 | Conversion of derivative security | 0.00 |
| Sep 11, 2024 | Raymond A. Ritchey Senior EVP | N/A | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $74.25 per share | 0.00 |
| Apr 2, 2024 | Kelly Ann Ayotte Director | 8,028 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 7, 2024 | Raymond A. Ritchey Senior EVP | 102,955 | Conversion of derivative security | 0.00 |
| Mar 7, 2024 | Raymond A. Ritchey Senior EVP | 88,805 | Conversion of derivative security | 0.00 |
| Mar 7, 2024 | Raymond A. Ritchey Senior EVP | 17,115 | Conversion of derivative security | 0.00 |
| Mar 7, 2024 | Raymond A. Ritchey Senior EVP | 156,813 | Conversion of derivative security | 0.00 |
| Mar 1, 2024 | Eric G. Kevorkian SVP, CLO and Secretary | 806 | Bona fide gift | 0.00 |
| Feb 9, 2024 | Douglas T. Linde President; Director | 562,745 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 9, 2024 | Robert E. Pester Executive Vice President of GP | 100,142 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 9, 2024 | Rodney C. Diehl Executive Vice President | 38,769 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 9, 2024 | Owen D. Thomas Chief Executive Officer of GP; Director | 763,066 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 9, 2024 | John J Stroman Executive Vice President of GP | 51,355 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |